2026-10-14T06:29:44Z https://api.figshare.com/v2/oai

oai:figshare.com:article/29068586 2026-09-30T07:01:39Z category_382 portal_81 item_type_3 month_year_09_2026

Neoadjuvant SHR-A1811 Monotherapy in Hormone Receptor-positive, HER2-low Breast Cancer: A Phase 2 Clinical Trial (HELEN-015) Dechuang Jiao (21363706) Jiujun Zhu (21363709) Xianfu Sun (21363712) Zhenduo Lu (21363715) Jianghua Qiao (21363717) Xiuchun Chen (21363705) Chengzheng Wang (21363703) Min Yan (21363720) Chongjian Zhang (21363721) Lianfang Li (21363729) JianFei Wang (21363732) Min Jin (21363723) Yijia Wu (21363735) Zhenzhen liu (21363727) Cancer Therapy (excl. Chemotherapy and Radiation Therapy) SHR-A1811 HER2-low HR-positive Neoadjuvant Clinical and Pathological Response Data from HELEN-015 Trial: Neoadjuvant SHR-A1811 Monotherapy in HR+/HER2-low Breast Cancer 2026-09-30T07:01:39Z Dataset Dataset 10.6084/m9.figshare.29068586.v1 https://figshare.com/articles/dataset/Neoadjuvant_SHR-A1811_Monotherapy_in_Hormone_Receptor-positive_HER2-low_Breast_Cancer_A_Phase_2_Clinical_Trial_HELEN-015_/29068586 CC BY 4.0